(Q46697169)

24 December 2017

title

The effect of 12-week open-label memantine treatment on cognitive function improvement in patients with alcohol-related dementia (English)

1 reference

24 December 2017

0 references

Younghoon Cheon

1

0 references

author name string

Jaewoo Park

series ordinal

2

1 reference

24 December 2017

Keun-Ho Joe

series ordinal

3

1 reference

24 December 2017

Dai-Jin Kim

series ordinal

4

1 reference

24 December 2017

publication date

17 March 2008

1 reference

24 December 2017

The International Journal of Neuropsychopharmacology

published in

1 reference

24 December 2017

volume

11

1 reference

24 December 2017

issue

7

1 reference

24 December 2017

page(s)

971-983

1 reference

24 December 2017

A new clinical scale for the staging of dementia.

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

21 January 2018

Ethanol and brain damage

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

Aging, abstinence, and medical risk factors in the prediction of neuropsychologic deficit among long-term alcoholics

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

Memantine treatment in alcohol dementia: rapid PET changes and clinical course

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

Effects of memantine on behavioural symptoms in Alzheimer's disease patients: an analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

Construct validity in the trail making test: What makes part B harder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

Glutamatergic substrates of drug addiction and alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

A pilot double-blind treatment trial of memantine for alcohol dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

Glutamate-mediated transmission, alcohol, and alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

High prevalence of hyperhomocysteinemia in chronic alcoholism: the importance of the thermolabile form of the enzyme methylenetetrahydrofolate reductase (MTHFR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

Primary alcoholic dementia and alcohol-related dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

The Neuropsychiatric Inventory: assessing psychopathology in dementia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

Acetylcholinesterase inhibitors for the treatment of Wernicke-Korsakoff syndrome--three further cases show response to donepezil

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

Fluvoxamine treatment of alcoholic amnestic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

Cognitive loss and recovery in long-term alcohol abusers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

Memantine inhibits ethanol-induced NMDA receptor up-regulation in rat hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

Homocysteine as a neurotoxin in chronic alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

Memantine, but not dizocilpine, ameliorates cognitive deficits in adult rats withdrawn from chronic ingestion of alcohol

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

Plasma homocysteine is a predictor of alcohol withdrawal seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

Recovery of hippocampus-related functions in chronic alcoholics during monitored long-term abstinence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

Short-term cognition deficits during early alcohol withdrawal are associated with elevated plasma homocysteine levels in patients with alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

Development of the Korean version of the Consortium to Establish a Registry for Alzheimer's Disease Assessment Packet (CERAD-K): clinical and neuropsychological assessment batteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

Chronic ethanol consumption increases homocysteine accumulation in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

Alcohol abuse, cognitive impairment, and mortality among older people

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

Anticholinesterase drugs for alcoholic Korsakoff syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

Wernicke-Korsakoff syndrome and alcohol-induced persistent dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

Effect of memantine on cue-induced alcohol craving in recovering alcohol-dependent patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

A normative study of the Trail Making Test in Korean elders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

Psychotogenicity and N-methyl-D-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

Donepezil for alcohol-related dementia: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

Homocysteine and brain atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

Binge drinking in midlife and dementia risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

A case of Korsakoff's syndrome improved by high doses of donepezil

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

The Global Deterioration Scale for assessment of primary degenerative dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

Evidence for alcohol anti-craving properties of memantine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

7 January 2021

Ethanol-reinforced behaviour in the rat: effects of uncompetitive NMDA receptor antagonist, memantine

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

7 January 2021

Noncompetitive NMDA receptor antagonists with fast open-channel blocking kinetics and strong voltage-dependency as potential therapeutic agents for Alzheimer's dementia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

7 January 2021

Neuroprotective and symptomatological action of memantine relevant for Alzheimer's disease--a unified glutamatergic hypothesis on the mechanism of action.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

7 January 2021

Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

7 January 2021

Pharmacological mechanisms of naltrexone and acamprosate in the prevention of relapse in alcohol dependence.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

7 January 2021

Effect of physical layout in performance of the Trail Making Test

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

7 January 2021

The interactive effects of age and length of abstinence on the recovery of neuropsychological functioning in chronic male alcoholics: a 2-year follow-up study.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

7 January 2021

Neurocognitive impairment associated with alcohol use disorders: implications for treatment

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008663

7 January 2021

10.1017/S1461145708008663

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017